MS

4 Key Drug Approvals Expected In The Next 30 Days
investors.com
Sat, 03/16/13 - 10:55 am
Biogen Idec
BG-12
multiple sclerosis
MS
Remodulin
United Therapeutics
lung disease
Invokana
JNJ
diabetes
type 2 diabetes
Levadex
Allergan
migraine
Teva Enrolls Patients in MS Study - Analyst Blog
NASDAQ
Sat, 03/9/13 - 12:43 pm
laquinimod
Teva Pharmaceuticals
multiple sclerosis
MS
Coronado Biosciences: 2013 - Year Of The Worm
Seeking Alpha
Sun, 03/3/13 - 11:45 am
TSO
autoimmune disease
multiple sclerosis
MS
Chron's Disease
ulcerative colitis
acute myeloid leukemia
A Strong Growth Opportunity In Multiple Sclerosis
Motley Fool
Wed, 02/20/13 - 11:46 am
multiple sclerosis
MS
Elan
Biogen Idec
Tysabri
Teva
XenoPort
Sanofi
BG-12
A Win-Win Multiple Sclerosis Deal?
Motley Fool
Thu, 02/7/13 - 10:10 am
MS
multiple sclerosis
Tysabri
Biogen Idec
Elan
Merck KGaA signs $225 million personalized MS drug deal
Pharma Times, UK
Wed, 02/6/13 - 11:11 am
Merck KGaA
MS
Tcelna
multiple sclerosis
Opexa
Biogen pays Elan $3.25 billion to take over MS drug
Reuters
Wed, 02/6/13 - 08:25 am
Biogen Idec
Elan
Tysabri
M&A
MS
multiple sclerosis
Sanofi says FDA starts review of new MS drug Lemtrada; decision due in late 2013
Yahoo/AP
Mon, 01/28/13 - 12:30 pm
FDA
Lemtrada
Sanofi
MS
multiple sclerosis
Biogen’s Longer-Lasting MS Drug Meets Goals in Late Trial
Bloomberg
Thu, 01/24/13 - 10:33 am
MS
Biogen Idec
multiple sclerosis
peginterferon beta-1a
Is Teva Just Looking Out for Itself
Motley Fool
Sat, 01/12/13 - 11:14 am
Teva
Copaxone
multiple sclerosis
MS
generics
Biogen
BG-12
1 Problem This Pharma Doesn’t Want to Talk About
Motley Fool
Sat, 01/12/13 - 10:36 am
Copaxone
Teva Pharmaceuticals
multiple sclerosis
MS
patents
1 Problem This Pharma Doesn’t Want to Talk About
Motley Fool
Sat, 01/12/13 - 10:36 am
Copaxone
Teva Pharmaceuticals
multiple sclerosis
MS
Teva Petitions FDA To Delay Biogen MS Drug
Pharmalot
Thu, 01/10/13 - 09:53 am
FDA
Teva
Biogen Idec
MS
multiple sclerosis
Copaxone
BG-12
2013 Should Be Interesting for Multiple Sclerosis Drugs
Motley Fool
Thu, 01/3/13 - 11:39 am
MS
multiple sclerosis
Teva
Copaxone
Rebif
Pfizer
Merck KGaA
Biogen Idec
Avonex
Bayer
Betaseron
Novartis
Extavia
Sanofi
Tysabri
Aubagio
Elan
Gilenya
BG-12
Overnight success proves elusive for oral MS drugs
Fierce Pharma
Tue, 11/20/12 - 01:25 pm
multiple sclerosis
MS
Novartis
Gilenya
Sanofi
Aubagio
5 Drug Hopefuls That Are Going to Change Your Life: Part 1
Motley Fool
Thu, 11/15/12 - 04:25 pm
BG-12
Biogen Idec
MS
multiple sclerosis
Teva Pharmaceuticals: Valuation Is Too Depressed On Worries About Copaxone
Seeking Alpha
Mon, 11/5/12 - 11:30 am
Teva
Copaxone
MS
multiple sclerosis
Sanofi draws fire over cost of MS drug Lemtrada
Reuters
Thu, 11/1/12 - 11:51 am
MS
multiple sclerosis
Sanofi
Lemtrada
New Developments In Lipids To Watch Closely
Seeking Alpha
Sun, 10/28/12 - 11:31 am
Lpath
Pfizer
iSONEP
Asonept
macular degeneration
multiple sclerosis
MS
Regeneron
Roche
Bayer
Sanofi
Valeant Pharmaceuticals
GSK
Biogen slips as FDA extends review of MS drug
Yahoo/AP
Sat, 10/20/12 - 10:29 am
Biogen
BG-12
MS
multiple sclerosis

Pages